These effects are generally not clinically significant for most medicines, but caution is advised with narrow therapeutic index drugs (e.g., warfarin, where INR monitoring may be appropriate)
In fact, jumping straight to high doses is a good way to end up with unpleasant side effects that may have you swearing off the stuff entirely
20, 2025, my team published a study of more than 2.4 million people that evaluated the risks and benefits of GLP-1 drugs across 175 possible health outcomes
This distinction is not intuitive, and it confuses even experienced practitioners
The standard caveat applies: if you have vomiting or diarrhoea from Wegovy, follow your usual missed pill guidance
Results The number of semaglutide fills increased by 442% between January 2021 and December 2023 (from 471 876 to 2 555 308), with Ozempic accounting for over 70% or more of semaglutide fills during this period (Figure)